pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,397 catalysts · 3,288 8k filing · 1,642 grant · 1,000 device adverse event · 755 approval · 597 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2026-02-10×clear all
type
  • 8k filing3,288
  • grant1,642
  • device adverse event1,000
  • approval755
  • device 510k597
  • earnings584
device pma
455
  • device recall178
  • phase 2 completion172
  • recall162
  • therapy area

    no tagged catalysts yet

    Week of Feb 9, 2026

    50
    ›Feb 10, 2026approval185d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Feb 10, 2026approval185d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Feb 10, 2026approval185d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval185d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUDROCORTISONE ACETATE — FDA approvalNovitium Pharma LLC

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoTRETINOIN — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: ENCUBE. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoSULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoGLYCOPYRROLATE — FDA approvalGLYCOPYRROLATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Feb 10, 2026approval185d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: HIKMA. Form: TABLET. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Feb 10, 2026grant185d agoNORTH DAKOTA STATE UNIVERSITY — Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancer

    GM grant. $224,737. PI: Elisabetta Liverani

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF WEST FLORIDA — NeuroNauts Scholars

    NS grant. $110,118. PI: RODNEY P GUTTMANN

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoKEYSTONE SYMPOSIA — Myeloid Cells: Functional Heterogeneity with Therapeutic Promise

    AI grant. $16,500. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — RpoS-independent gene regulation by the Borrelia burgdorferi Fur ortholog BosR

    AI grant. $457,875. PI: MELISSA J CAIMANO

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUT SOUTHWESTERN MEDICAL CENTER — Defining virulence factor functions using minimal pathogen genomes

    AI grant. $596,318. PI: Neal Mathew Alto

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF IOWA — Impact of whole-body radiation exposure on pathogen-specific memory CD8 T cellsUniversity of Iowa

    AI grant. $649,484. PI: VLADIMIR P BADOVINAC

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF COLORADO DENVER — Extracellular-Vesicle Derived Biomarkers in Diabetic NeuropathyUniversity of Colorado Denver

    DK grant. $117,000. PI: VERA FRIDMAN

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Applying novel tools to parse Plasmodium vivax relapses in clinical trials

    AI grant. $190,825. PI: Jessica Lin

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoHARVARD UNIVERSITY — Elucidating Biomolecular Dynamics using Magnetic Resonance Augmented by Machi...

    GM grant. $142,182. PI: Kushal Seetharam

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoINDIANA UNIVERSITY INDIANAPOLIS — Dysregulation of humoral immunity following Plasmodium infection

    AI grant. $790,946. PI: Nathan Schmidt

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoTEMPLE UNIV OF THE COMMONWEALTH — Lung-on-a-Chip and Spatial Transcriptomics to Define Eicosanoid Roles in Muco...

    AI grant. $435,875. PI: Vincent Tam

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Deciphering HIV-1 Resistance Pathways against Capsid Inhibitors in vitro and ...

    AI grant. $790,847. PI: Zandrea Ambrose

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF CALIFORNIA-IRVINE — Molecular Architecture of the Vaccinia virus factory

    AI grant. $235,500. PI: Paul D Gershon

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoTUFTS UNIVERSITY BOSTON — Spatial multi-omics to predict granuloma trajectory and bacterial restriction...

    AI grant. $490,704. PI: Amanda Martinot

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF VIRGINIA — Decoding Human Immune Programs in Sequential Rhinovirus InfectionsUniversity of Virginia

    AI grant. $444,125. PI: Judith A Woodfolk

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoSALK INSTITUTE FOR BIOLOGICAL STUDIES — Molecular Pathways Leading to Drug Resistance in HIV-1 Integrase

    AI grant. $515,625. PI: Dmitry Lyumkis

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Dissecting a Novel Pathway for Degradative Endosome Generation during Rapid S...

    GM grant. $462,500. PI: Yuuta Imoto

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH — Maturation and maintenance of the germinal center niche

    AI grant. $460,625. PI: YONG-RUI ZOU

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF WISCONSIN-MADISON — Pathophysiology of Severe Yellow Fever

    AI grant. $729,189. PI: Adam Lee Bailey

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoBARUCH S. BLUMBERG INSTITUTE — Identification of cellular functions involved in Hepatitis B Virus infection ...

    AI grant. $195,750. PI: Liudi Tang

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Reengineering Fibroblast Growth Factor 2 to Address Allograft VasculopathyNorthwestern University

    AI grant. $440,000. PI: SATISH N NADIG

    full page →nih reporter ↗
    ›Feb 10, 2026grant185d agoUNIVERSITY OF NEBRASKA LINCOLN — Regeneration of lymphatic valve after injury

    GM grant. $160,566. PI: Mohammad Razavi Rizi

    full page →nih reporter ↗
    ›Feb 11, 2026approval184d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval184d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

    Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 11, 2026approval184d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Feb 11, 2026approval184d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Feb 11, 2026approval184d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval184d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval184d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval184d agoBRIMONIDINE TARTRATE — FDA approvalBausch & Lomb Corp

    Sponsor: DR REDDYS LABS SA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF TEXAS SAN ANTONIO — Development of small molecule inhibitors of RBM46 as novel male contraceptives

    HD grant. $743,116. PI: Christopher Bennett Geyer

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoCLEVELAND CLINIC LERNER COM-CWRU — Pathogenesis of Permanent Neurological Disability in Multiple Sclerosis

    NS grant. $544,568. PI: BRUCE D TRAPP

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF IOWA — Identifying novel regulators of Tfh cell differentiation that can be targeted...University of Iowa

    AI grant. $427,625. PI: Ryan Zander

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A parabrachial hub for the prioritization of pain and other survival behaviors

    NS grant. $620,504. PI: John Nicholas Betley

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF PENNSYLVANIA — Single-nucleus gene expression and chromatin accessibility profiling of sleep...University of Pennsylvania

    NS grant. $243,750. PI: Xiaofeng Guo

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF DELAWARE — Evaluating Force Deficits During Bimanual Coordination in Parkinson's Disease...Metallomix Inc

    NS grant. $80,000. PI: Roxana Gabriela Burciu

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoBAYLOR COLLEGE OF MEDICINE — STATE-DEPENDENT MODULATION OF CEREBELLAR FUNCTIONBaylor College of Medicine

    NS grant. $508,533. PI: JAVIER F MEDINA

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoUNIVERSITY OF PENNSYLVANIA — The impact of a personalized video-based stroke educational platform onpatien...University of Pennsylvania

    NS grant. $644,345. PI: Christopher G. Favilla

    full page →nih reporter ↗
    ›Feb 11, 2026grant184d agoINDIANA UNIVERSITY INDIANAPOLIS — World Parkinson Congress 2026 Support

    NS grant. $25,000. PI: Maria de Lourdes Gamez Tansey

    full page →nih reporter ↗
    ← prev
    page 1 of 48
    next →
    $PFE26.80+1.86%
    $BLCO16.98+1.31%
    $PFE26.80+1.86%